期刊文献+

去整合素和金属蛋白酶17调控胰腺癌细胞增殖凋亡的机制 被引量:4

Mechanisms of ADAM17/TACE regulating proliferation and apotosis of pancreatic ductal adenocarcinoma cells
原文传递
导出
摘要 目的探讨去整合素和金属蛋白酶17(ADAM17/TACE)调控胰腺癌细胞增殖凋亡的作用机制。方法分别采用免疫组织化学及流式细胞仪检测58例胰导管腺癌组织及6株胰腺癌细胞株中ADAM17/TACE的表达,用小RNA干扰(siRNA)技术去除胰腺癌细胞k3.6plADAM17/TA—CEmRNA及蛋白表达后,CCK-8试剂盒检测胰腺癌细胞L3.6pl的生长速度,Westernblot检测AD—AM17/TACE、凋亡相关基因PARP、增殖相关基因p27(p27kip1)表达。阻断表皮生长因子受体(EG—FR)及丝氨酸苏氨酸蛋白激酶(AKT)通路后,Westernblot检测ADAM17/TACE及EGFR/p—EGFR、AKT/p-AKT的表达变化。结果58例胰导管腺癌组织及6株胰腺癌细胞中ADAM17/TACE的表达阳性率均为100%。同亲代L3.6pl细胞比较,siRNA干扰ADAM17/TACEmRNA的表达后,L3.6pl细胞生长速度减缓(P〈0.05);p27kip1的表达明显增强;多聚二磷酸腺苷核糖聚合酶(PARP)表达亦明显增强提示出现凋亡;分别阻断EGFR和磷脂酰肌醇3激酶(P13K)/AKT信号通路后,AD—AM17/TACE蛋白表达均增加。结论ADAM17/TAcE调控胰腺癌细胞增殖,抑制其表达可致胰腺癌细胞凋亡,可能与P13K/AKT信号通路相关。 Objective To study the mechanisms of ADAM17/TACE regulating proliferation and apoptosis of pancreatic ductal adenocarcinoma cells. Methods The expression of ADAM17/TACE in 58 cases of pancreatic ductal adenocarcinoma tissues and 6 pancreatic cancer cell lines were detected by using immunohistochemistry and FACS. After small interfering RNA (siRNA) to block the expression of AD- AM17/TACE, cell proliferation and apoptosis were analyzed by using CCK-8 Kit and poly (ADP-ribose) polymerase (PARP) Western blotting. After inhibiting epidermal growth factor receptor (EGFR) and AKT passway, the expression levels of ADAM17/TACE and EGFR/p-EGFR, AKT/p-AKT were detected by u- sing Western blotting. Results The positive ratio of ADAM17/TACE expression was 100% in 58 cases of pancreatic ductal adenocarcinoma tissues and 6 pancreatic cancer cell lines. The results of CCK-8 assay indicated the proliferation of L3.6pl cancer cell was markly slower after transfering siRNA to block the expression of ADAM17/TACE mRNA (P 〈 0. 05 ). The results of Western blotting revealed that the expression of ADAM17/TACE was down-regulated by ADAM17/TACE-siRNA in 13.6pl cancer cells, but the expression of p27kip1 and PARP markedly up-regulated after the 13.6 cancer ceils treated with siRNA. After inhibition of the EGFR-phosphatidylinositol 3 kinase (PI3K)/AKT signaling pathway, the expression of ADAM17/TACE was increased by Western blotting. Conclusion It is suggested that ADAM17/TACE could modulate proliferation of pancreatic cancer ceils and blocking ADAM17/TACE expression could induced apoptosis of pancreatic cancer ceils probably via EGFR-PI3K/AKT pathway.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第10期1716-1719,共4页 Chinese Journal of Experimental Surgery
基金 河南省医学科技攻关计划资助项目(200803117)
关键词 胰腺癌 表皮生长因子受体 丝氨酸苏氨酸蛋白激酶 Pancreatic carcinoma EGFR AKT
  • 相关文献

参考文献10

  • 1于洪亮,王夫景,杨维良.ADAm23基因的研究现状与展望[J].中华实验外科杂志,2007,24(9):1151-1152. 被引量:1
  • 2Black RA, Rauch CT, Kozlosky C J, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature, 1997,385:729-733.
  • 3Andreas G, Stefan H, Oliver M, et al. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J,2003,22:2411-2421.
  • 4Wu E, Croucher PI, McKie N, eta]. Expression of members of the novel membrane linked metalloproteinase family ADAM in cells derived from a range of haematological malignancies. Biochem Biophys Res Commun, 1997,235:437-442.
  • 5Zhang Q, Thomas SM, Lui VW, et al. Phosphorylation of TNF-α converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation. Proe Natl Aead Sei USA,2006, 103 : 6901-6906.
  • 6McCullocb DR, Harvey M, Herington AC. The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosterone. Mol Cell Endocrinol,2000,167 : 11-21.
  • 7Kenny PA. TACE : a new target in epidermal growth factor receptor dependent tumors. Differentiation,2007,75:800-808.
  • 8Sternlicht MD, Sunnarborg SW. The ADAM17-amphiregulin-EGFR axis in mammary development and cancer. J Mammary Gland Biol Neoplasia,2008,13 : 181-194.
  • 9Sallmann FR, Bourassa S, Saint-Cyr J, et al. Characterization of antibodies specific for the caspase cleavage site on poly ( ADP-ribose ) polymerase:spccific detection of apoptotic fragments and mapping of the necrotic fragments of poly(ADP-ribose) polymerase. Biochem Cell Biol, 1997,75:451-456.
  • 10管洪庚,徐永峰,兰晶.血小板源生长因子通过PI3K/AKT途径促肝星状细胞增殖与Ⅰ型胶原合成[J].中华实验外科杂志,2007,24(11):1332-1334. 被引量:17

二级参考文献24

  • 1柴丽,石林祥,房林,卢少毅,孙健.KiSS-1基因及其受体在乳腺癌中的表达及临床意义[J].中华实验外科杂志,2005,22(9):1068-1070. 被引量:6
  • 2陈剑英,张波,王国斌,陈庆勇,陈道达.抑癌基因PTEN在乳腺癌激素耐受细胞中的表达[J].中华实验外科杂志,2005,22(10):1195-1197. 被引量:7
  • 3Primakoff P, Myles DG. The ADAM gene family:surface proteins with adhesion and protease activity. Trends Genet, 2000,16 : 83-87.
  • 4Sagane K,Ohya Y, Hasegawa Y, et al. Metalloproteinase-like, disintegrin-like, cysteine-rich proteins MDC2 and MDC3:novel human cellular disintegrins highly expressed in the brain. Biochem J, 1998, 334:93 -98.
  • 5Seals DF, Courtneidge SA. The ADAMs family of metalloproteases : multidomain proteins with multiple functions. Genes Dev, 2003,17:7-30.
  • 6Watabe-Uchida M, Masuda A, Shimada N, et al. Novel metalloprotease-disintegrin, meltrin epsilon ( ADAM35 ), expressed in epithelial tissues during chick embryogenesis. Dev Dyn ,2004,230:557-568.
  • 7Sun YP,Deng KJ,Wang F,et al. Two novel isoforms of Adam23 expressed in the developmental process of mouse and human brains. Gene,2004,325 : 171-178.
  • 8Yavari R, Adida C, Bray-Ward P, et al. Human metalloprotease-disintegrin Kuzbanian regulates sympathoadrenal cell fate in development and neoplasia. Hum Mol Genet, 1998,7 : 1161-1167.
  • 9Calmon MF,Colombo J,Carvalho F,et al. Methylation profile of genes CDKN2A ( p14 and p16), DAPK1, CDH1, and AD- Am23 in head and neck cancer. Cancer Genet Cytogenet ,2007,173:31-37.
  • 10Cal S, Frelje JM, Lopez JM, et al. ADAM 23/MDC3, a human disintegrln that promotes cell adhesion via interaction with the alphavbeta3 integrin through an RGD- independent mechanism. Mol Biol Cell, 2000,11 : 1457-1469.

共引文献16

同被引文献33

  • 1臧琦,蒋仲敏,王伟,杨宜娥,朱强,王连生.肺癌胸腔积液CEA和CYFRA21-1及NSE术中联检的临床价值[J].中华肿瘤防治杂志,2006,13(17):1310-1312. 被引量:5
  • 2陆熊熊,陆爱国.解聚素-金属蛋白酶家族剪切活化作用及其研究[J].上海预防医学,2007,19(8):423-426. 被引量:1
  • 3Zhou BB, Fridman JS, Liu X, et al. ADAM proteases, ErbB pathways and cancer [J]. Expert Opin Investig Drugs,2005,14 (6): 591-606.
  • 4Stone AL,Kroeger M,Sang QX. Structure-function analy- sis of the ADAM family of disintegrin-like and metallopro- teinase-containing proteins (review) [J]. J Protein Chem, 1999,18(4): 447-465.
  • 5McGowan PM,Ryan BM,Hill AD,et al. ADAM-17 expres- sion in breast cancer correlates with variables of tumor pro- gression [J]. Clin Cancer Res,2007,13(8): 2335-2343.
  • 6Katakowski M,Jiang F,Zheng X,et al. Tumorigenicity of cortical astrocyte cell line induced by the protease ADAMI7[J]. Cancer Sci, 2009,100(9): 1597-1604.
  • 7Wu X,Deng Y,Wang G,et al. Combining siRNAs at two different sites in the EGFR to suppress its expression,in- duce apoptosis,and enhance 5-fluorouraeil sensitivity of colon cancer cells[J]. J Surg Res,2007,138(1):56-63.
  • 8Borrell-Pages M,Rojo F,Albanell J,et al. TACE is re- quired for the activation of the EGFR by TGF-alpha in tu- mors [J]. EMBO J,2003,22 (5): 1114-1124.
  • 9McGowan PM, Ryan BM,Hill AD,et al. ADAM-17 expres- sion in breast cancer correlates with variables of tumor progression [J]. Clin Cancer Res,2007,13(8): 2335-2343.
  • 10McGowan PM, McKiernan E, Bolster F, et al. ADAM-17 predicts adverse outcome in patients with breast cancer [J]. Ann Oncol, 2008,19(6) :1075-1081.

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部